$MAIA
MAIA Biotechnology, Inc.
XASE•Health Care•Pharmaceutical Preparations
$1.37
▼-2.14%-$0.030
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateMAIA Biotechnology, Inc.
XASE•Health Care•Pharmaceutical Preparations
Why is MAIA down today? It is at $1.37 (-2.14%), and our scanner flagged it 25 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment MAIA spikes, and full due diligence on MAIA — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $MAIA 25 times in the last 30 days. Create a free account to track $MAIA, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on MAIA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for MAIA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
From the trading subreddits (WallStreetBets, r/stocks and more). Retail chatter, not a signal. Do your own research.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Vitoc Vlad Officer | Bought (open market) | +73K 0.1% of company | added 7.5% | 1.05M | $100K at $1.37 | Sep 14, 26 |
Guerrero Ramiro Director | Bought (open market) | +38K 0.06% of company | added 5.1% | 773K | $50K at $1.32 | Sep 10, 26 |
Guerrero Ramiro Director | Bought (open market) | +47K 0.08% of company | added 6.8% | 736K | $63K at $1.35 | Aug 28, 26 |
Guerrero Ramiro Director | Bought (open market) | +78K 0.1% of company | added 13% | 689K | $109K at $1.39 | Aug 27, 26 |
Guerrero Ramiro Director | Bought (open market) | +9K 0.01% of company | added 1.5% | 611K | $12K at $1.39 | Aug 26, 26 |
Guerrero Ramiro Director | Bought (open market) | +2K | added 0.3% | 602K | $2K at $1.33 | Aug 24, 26 |
Guerrero Ramiro Director | Bought (open market) | +12K 0.02% of company | added 2.0% | 600K | $16K at $1.37 | Aug 20, 26 |
Gryaznov Sergei Officer | Bought (open market) | +2K | added 4.5% | 47K | $3K at $1.34 | Jun 1, 26 |
Smith Stan Director | Bought (open market) | +75K 0.1% of company | added 5.1% | 1.53M | $101K at $1.34 | Jun 1, 26 |
Vitoc Vlad Officer | Bought (open market) | +73K 0.1% of company | added 8.0% | 976K | $101K at $1.39 | Jun 1, 26 |
Louie Ngar Yee Director | Bought (open market) | +82K 0.1% of company | added 7.0% | 1.25M | $100K at $1.22 | Dec 22, 25 |
Chaouki Steven M Director | Bought (open market) | +41K 0.07% of company | added 37% | 152K | $50K at $1.22 | Dec 22, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on MAIA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for MAIA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
MAIA last traded at $1.37, down 2.14% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
MAIA Biotechnology, Inc. (MAIA) is next expected to report earnings on Friday, November 6, 2026, about 50 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The MAIA Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged MAIA 25 times in the last 30 days.
MAIA (MAIA Biotechnology, Inc.) trades on XASE, with a market cap of about $85M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge MAIA for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$MAIA discussion
Sign in to ask a question or join the discussion.